Skip to main content

Quantitative Assessment of Reactive Metabolites

  • Protocol
  • First Online:
Optimization in Drug Discovery

Part of the book series: Methods in Pharmacology and Toxicology ((MIPT))

  • 2648 Accesses

Abstract

Quantitation of reactive intermediates from bioactivation of drug via covalent protein binding using radiolabeled drug is the gold standard for quantitation of reactive metabolite formation in the absence of synthetic standard. However, radiolabeling many compounds during lead optimization can be resource intensive and expensive, which led to development of alternative method for quantitation of reactive metabolites using trapping agents as a surrogate to covalent protein binding. Quantitation of reactive metabolite formation using trapping agents can be broadly divided into two categories: (1) Radiolabeled trapping agents such as [35S]-cysteine, [35S]-glutathione, [3H]-glutathione and [14C]-cyanide. In general, the concentration of the radiolabeled adducts of reactive intermediates can be calculated from the peak area in dpm and the specific activity. (2) Non-radiolabeled trapping agents such as dansyl glutathione and quaternary ammonium glutathione analogs. Here quantitation is based on the intrinsic spectroscopic property of the chemical tag, for example, the dansyl glutathione adduct is quantitated using the emission and excitation wavelength of the fluorescence dansyl moiety. On the other hand, quantitation of quarternary ammonium glutathione conjugate is dependent on the similarity in MS responses of the precursor molecular ion and similar efficiency in formation of the product ion containing the quarternary ammonium moiety of analyte and internal standard. In this chapter, we will describe the experimental procedures for quantitation of reactive metabolite formation using these trapping agents.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Liebler DC, Guengerich FP (2005) Elucidating mechanisms of drug-induced toxicity. Nat Rev Drug Discov 4:410–420

    Article  PubMed  CAS  Google Scholar 

  2. Walgren JL, Mitchell MD, Thompson DC (2005) Role of metabolism in drug-induced idiosyncratic hepatotoxicity. Crit Rev Toxicol 35:325–361

    Article  PubMed  CAS  Google Scholar 

  3. Baillie TA (2006) Future of toxicology-metabolic activation and drug design: challenges and opportunities in chemical toxicology. Chem Res Toxicol 19:889–893

    Article  PubMed  CAS  Google Scholar 

  4. Evans DC, Baillie TA (2005) Minimizing the potential for metabolic activation as an integral part of drug design. Curr Opin Drug Discov Devel 8:44–50

    PubMed  CAS  Google Scholar 

  5. Amacher DE (2006) Reactive intermediates and the pathogenesis of adverse drug reactions: the toxicology perspective. Curr Drug Metab 7:219–229

    Article  PubMed  CAS  Google Scholar 

  6. Doss GA, Baillie TA (2006) Addressing metabolic activation as an integral component of drug design. Drug Metab Rev 38:641–649

    Article  PubMed  CAS  Google Scholar 

  7. Tang W (2007) Drug metabolite profiling and elucidation of drug-induced hepatotoxicity. Expert Opin Drug Metab Toxicol 3:407–420

    Article  PubMed  CAS  Google Scholar 

  8. Caldwell GW, Yan Z (2006) Screening for reactive intermediates and toxicity assessment in drug. Curr Opin Drug Discov Devel 9:47–60

    PubMed  CAS  Google Scholar 

  9. Uetrecht J (2003) Screening for the potential of a drug candidate to cause idiosyncratic drug reactions. Drug Discov Today 8:832–837

    Article  PubMed  CAS  Google Scholar 

  10. Day SH, White R, Schulz-Utermoehl T, Miller R, Beconi MG (2005) A semi-automated method for measuring the potential for protein covalent binding in drug discovery. J Pharmacol Toxicol Methods 52:278–285

    Article  PubMed  CAS  Google Scholar 

  11. Evans DC, Watt AP, Nicoll-Griffith DA, Baillie TA (2004) Drug-protein adducts: an industry perspective on minimizing the potential for drug bioactivation in drug discovery and development. Chem Res Toxicol 17:3–16

    Article  PubMed  CAS  Google Scholar 

  12. Masubuchi N, Makino C, Murayama N (2007) Prediction of in vivo potential for metabolic activation of drugs into chemically reactive intermediates: correlation of in vitro and in vivo generation of reactive intermediates and in vitro glutathione conjugate formation in rats and human. Chem Res Toxicol 20:455–464

    Article  PubMed  CAS  Google Scholar 

  13. Mulder GJ, Le CT (1988) A rapid, simple in vitro screening test, using [3H]glutathione and L-[35S]cysteine as trapping agents, to detect reactive intermediates of xenobiotics. Toxicol In Vitro 2:225–230

    Article  PubMed  CAS  Google Scholar 

  14. Hartman NR, Cysyk RL, Bruneau-Wack C, Thenot JP, Parker RJ, Strong JM (2002) Production of intracellular 35S-glutathione by rat and human hepatocytes for the quantification of xenobiotics reactive intermediates. Chem Biol Interact 142:43–55

    Article  PubMed  CAS  Google Scholar 

  15. Takakusa H, Masumoto H, Makino C, Okazaki O, Sudo K (2009) Quantitative assessment of reactive metabolite formation using 35S-labeled glutathione. Drug Metab Pharmacokinet 24(1):100–107

    Article  PubMed  CAS  Google Scholar 

  16. Inoue K, Shibata Y, Ttakahashi H, Ohe T, Chiba M, Ishii Y (2009) A trapping method for semi-quantitative assessment of reactive metabolite formation using [35S]Cysteine and [14C]Cyanide. Drug Metab Pharmacokinet 24(3):245–254

    Article  PubMed  CAS  Google Scholar 

  17. Gan J, Harper TW, Hsueh MM, Qu Q, Humphreys WG (2005) Dansyl glutathione as a trapping agent for the quantitative estimation and identification of reactive metabolites. Chem Res Toxicol 18:896–903

    Article  PubMed  CAS  Google Scholar 

  18. Gan J, Ruan Q, He B, Zhu M, Shyu WC, Humphreys WG (2009) In vitro screening of 50 highly prescribed drugs for thiol adduct formations. Comparison of potential for drug-induced toxicity and extent of adduct formation. Chem Res Toxicol 22:690–698

    Article  PubMed  CAS  Google Scholar 

  19. Soglia RJ, Contillo GL, Kalgutkar SA, Zhao S, Hop ECAC, Boyd GJ, Cole JM (2006) A semiquantitative method for the determination of reactive metabolite conjugate levels in vitro utilizing liquid chromatography-tandem mass spectrometry and novel quaternary ammonium glutathione analogues. Chem Res Toxicol 19:480–490

    Article  PubMed  CAS  Google Scholar 

  20. Hinson JA, Reid AB, McCullough SS, James LP (2004) Acetaminophen-induced hepatotoxicity: role of metabolic activation, reactive oxygen/nitrogen species, and mitochondrial permeability transition. Drug Metab Rev 36:805–822

    Article  PubMed  CAS  Google Scholar 

  21. Maggs JL, Williams D, Pirmohamed M, Park BK (1995) The metabolic formation of reactive intermediates from clozapine, a drug associated with agranulocytosis in man. J Pharmacol Exp Ther 275:1463–1475

    PubMed  CAS  Google Scholar 

  22. Berson A, Wolf C, Chachaty C, Fisch C, Fau D, Eugene D, Loeper J, Gauthier JC, Beaune P, Pompon D (1993) Metabolic activation of the nitroaromatic antiandrogen flutamide by rat and human cytochromes P-450, including forms belonging to the 3A and 1A subfamilies. J Pharmacol Exp Ther 265:366–372

    PubMed  CAS  Google Scholar 

Download references

Acknowledgements

The views expressed here are solely those of the author and do not reflect the opinions of Janssen Research & Development, LLC.

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this protocol

Cite this protocol

Chen, J., Xu, R.F., Lam, W.W., Silva, J., Lim, HK. (2014). Quantitative Assessment of Reactive Metabolites. In: Caldwell, G., Yan, Z. (eds) Optimization in Drug Discovery. Methods in Pharmacology and Toxicology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-742-6_29

Download citation

  • DOI: https://doi.org/10.1007/978-1-62703-742-6_29

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-62703-741-9

  • Online ISBN: 978-1-62703-742-6

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics